These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 13450735)

  • 21. Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion?
    Amezcua-Guerra LM
    J Rheumatol; 2009 Jan; 36(1):4-6. PubMed ID: 19208528
    [No Abstract]   [Full Text] [Related]  

  • 22. [L.E. phenomenon in rheumatoid arthritis].
    Rev Clin Esp; 1957 Oct; 67(1):45-6. PubMed ID: 13527919
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ; Schur PH
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden.
    Sundquist K; Li X; Hemminki K; Sundquist J
    Arch Gen Psychiatry; 2008 May; 65(5):501-7. PubMed ID: 18458201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Straub RH; Weidler C; Demmel B; Herrmann M; Kees F; Schmidt M; Schölmerich J; Schedel J
    Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of disseminated lupus erythematosus and rheumatoid arthritis with methylprednisolone.
    McMAHON FG; GORDON ES
    J La State Med Soc; 1959 Jun; 111(6):201-10. PubMed ID: 13665203
    [No Abstract]   [Full Text] [Related]  

  • 28. Rheumatoid arthritis and the positive L.E.-cell phenomenon.
    GOSLINGS J; HIJMANS W; KIEVITS JH; SCHUTT HR
    Ann Rheum Dis; 1956 Sep; 15(3):211-6. PubMed ID: 13363251
    [No Abstract]   [Full Text] [Related]  

  • 29. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
    Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
    Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus.
    Cutolo M
    J Rheumatol; 2004 Mar; 31(3):419-21. PubMed ID: 14994382
    [No Abstract]   [Full Text] [Related]  

  • 33. A deiminated viral peptide to detect antibodies in rheumatoid arthritis.
    Merlini G; Anzilotti C; Chimenti D; Tommasi C; Bombardieri S; Migliorini P
    Ann N Y Acad Sci; 2005 Jun; 1050():243-9. PubMed ID: 16014539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical investigation on the L.E. cell phenomenon in patients with a rheumatoid arthritis syndrome.
    GOSLINGS J
    Acta Med Scand Suppl; 1958; 341():83-7. PubMed ID: 13605631
    [No Abstract]   [Full Text] [Related]  

  • 35. The incidence of the L.E. cell phenomenon in patients with rheumatoid arthritis (a two-year study).
    SIGLER JW; MONTO RW; ENSIGN DC; WILSON GM; REBUCK JW; LOVETT JD
    Arthritis Rheum; 1958 Apr; 1(2):115-21. PubMed ID: 13535307
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prolactin response to stress in patients with systemic lupus erythematodes (SLE), rheumatoid arthritis (RA) and in healthy controls].
    Dostál C; Fojtíková M; Lacinová Z; Cerná M; Moszkorzová L; Zvárová J; Marek J
    Vnitr Lek; 2007 Dec; 53(12):1265-8. PubMed ID: 18357860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LE phenomenon in articular fluids in primary chronic polyarthritis.
    HYNEK K
    Cas Lek Cesk; 1957 Jul; 96(29):911-4. PubMed ID: 13461028
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in centres in East Anglia and the South East.
    Teir J; Koduri G; Meadows A; Griffin J; Kelsey C; Kola A; Persey M; Sinclair H; Yuksel F; Moshtaghi P; Ramabhadram B; Poole K; Pradeep J; Lane S; Pountain G; Scott DG; Sheehan NJ; Stodell M; Young A; Hall FC
    Rheumatology (Oxford); 2008 Aug; 47(8):1252-4. PubMed ID: 18573801
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recurrent polyarthritis with alopecia, Raynaud's syndrome and positive L. E. test; remarks on the nosological problem of recurrent rheumatism].
    PIGUET B
    Rev Rhum Mal Osteoartic; 1957 Apr; 24(4):303-10. PubMed ID: 13466788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.